Artiva Biotherapeutics
CA - San DiegoBiotechnology
Focus: Artiva Biotherapeutics is a San Diego-based biotech company focused on developing allogeneic NK cell therapies for oncology and select autoimmune indications. The company operates in the highly competitive but underdeveloped cell therapy space with a targeted pipeline across multiple cancer types.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Open Jobs
25+3 this month
Stable — net +3 jobs in 30d
12 added, 9 removed. Backfill posture.
Should You Work at Artiva Biotherapeutics?
AI assessmentArtiva represents a high-opportunity, high-risk bet for cell therapy specialists seeking hands-on GMP and clinical exposure, but financial transparency and clinical validation are critical red flags for stability-focused candidates.
Why Work Here
- Access to cutting-edge NK cell therapy platform with recent FDA RMAT designation for allogeneic NK cells in refractory rheumatoid arthritis (June 2026), signaling regulatory momentum.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Artiva Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.